Latest Breaking News On - Zentalis pharmaceuticals - Page 7 : comparemela.com

Zentalis Pharmaceuticals Announces Inducement Grants Under

Zentalis Pharmaceuticals Announces Inducement Grants Under
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesNew yorkCarlo tanziZentalis pharmaceuticalsCompensation committee of zentali board directorsPharmaceuticals incZentalis pharmaceuticals incCompensation committeeZentali boardInducement incentive award planNasdaq listing ruleNasdaq global market

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01.04.2024 - NEW YORK and SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) - Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting .

New yorkUnited statesSan diegoCarlo tanziZentalis pharmaceuticalsZentalis pharmaceuticals incNasdaq global market

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesNew yorkCarlo tanziMark lacknerExchange commissionZentalis pharmaceuticalsPharmaceuticals incAmerican associationCancer researchSan diego aprilChief scientific officerTargeting kinaseSecurities litigation reform act

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoNew yorkCarlo tanziMark lacknerExchange commissionZentalis pharmaceuticalsPharmaceuticals incAmerican associationCancer researchSan diego aprilChief scientific officerPoster presentationTargeting kinaseLooking statementsthisSecurities litigation reform act

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSan diegoCarlo tanziZentalis pharmaceuticals incZentalis pharmaceuticalsPharmaceuticals incCompensation committee of zentali board directorsCompensation committeeZentali boardInducement incentive award planNasdaq listing ruleNasdaq global marketKendall investor